Clinical trial
DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use…
NCT00401687 · Lantheus Medical Imaging, Industry · Completed
Key facts
| NCT number | NCT00401687 |
|---|---|
| Title | DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use of Contrast Echocardiography to Assess Heart Function |
| Official title | A Multicenter, Phase IV Study to Evaluate the Ability of Definity® Enhanced Versus Unenhanced Echocardiography to Improve the Accuracy and Reproducibility of Left Ventricular Ejection Fraction When Compared to Cardiac Magnetic Resonance Imaging |
| Lead sponsor | Lantheus Medical Imaging, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Ventricular Ejection Fraction |
| Intervention type | Drug |
| Interventions | Definity® Vial for (Perflutren Lipid Microsphere) Injectable Suspension |
| Enrollment | 131 |
| Start date | Jul 1, 2006 |
| Primary completion | Jun 1, 2007 |
| Completion | Apr 1, 2008 |
| First posted | Nov 20, 2006 |
| Last update posted | May 20, 2011 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: